Sachem Capital Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 23, 2021, details a material definitive agreement and subsequent capital raise by Sachem Capital Corp. The report covers the entry into an underwriting agreement on June 23, 2021, and the consummation of the offering on June 29, 2021.
Key Financial Metrics and Transaction Details
- Transaction Type: Public offering of 7.75% Series A Cumulative Redeemable Preferred Stock.
- Shares Issued: 1,700,000 shares at a public offering price of $25.00 per share.
- Net Proceeds: Approximately $40.8 million (after underwriting discounts and commissions, before other expenses).
- Underwriting Price: $24.00 per share.
- Overallotment Option: Underwriters granted a 30-day option to purchase up to an additional 255,000 shares.
- Dividend Rate: 7.75% per annum ($1.9375 per share), payable quarterly.
- Liquidity Impact: The transaction significantly increases cash liquidity through the issuance of preferred equity.
Material Changes and Corporate Actions
The Company filed a Certificate of Amendment on June 25, 2021, to designate 1,955,000 authorized shares as Series A Preferred Stock. This issuance represents a new class of perpetual preferred equity with no stated maturity. The stock is listed on the NYSE American under the symbol "SACHPRA," with trading expected to commence on or about July 6, 2021.
Terms, Risks, and Management Commentary
- Redemption Terms: The stock is not redeemable before June 29, 2026, except upon a Change of Control. After this date, the Company may redeem shares at $25.00 per share plus accrued dividends.
- Change of Control: Upon a Change of Control, holders may convert shares into common stock based on a formula, or the Company may redeem the shares.
- Voting Rights: Holders generally do not have voting rights except under limited circumstances.
- Risks: The filing notes customary representations and warranties in the Underwriting Agreement. The perpetual nature of the stock and the obligation to pay cumulative dividends in arrears represent ongoing financial commitments.
Investor Verification Checklist
- Verify the final closing amount and whether the overallotment option was exercised.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification obligations.
- Confirm the exact commencement date of trading on the NYSE American.
- Assess the impact of the new $40.8 million in preferred dividends on the Company's future cash flow and earnings.
- Examine the Certificate of Amendment (Exhibit 3.1(c)) for specific definitions of "Change of Control" and conversion formulas.